Cervical cancer screening programs in Latin America: current recommendations for facing elimination challenges

Autores/as

  • Ginna Fernández-Deaza Centro Javeriano de Oncología, Hospital Universitario San Ignacio. Bogota, Colombia
  • Maria Caicedo-Martínez Centro Javeriano de Oncología, Hospital Universitario San Ignacio. Bogota, Colombia
  • Beatriz Serrano Cancer Epidemiology Research Program, Institut Català d’Oncologia, IDIBELL, L’Hospitalet de Llobregat. Barcelona, Spain
  • Esther Roura Centro de Investigación Biomédica en Red, Epidemiología y Salud Pública. Madrid, Spain
  • Juan Sebastián Castillo Facultad de Medicina, Pontificia Universidad Javeriana. Bogota, Colombia
  • Silvia de Sanjosé Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health. USA
  • Laia Bruni Cancer Epidemiology Research Program, Institut Català d’Oncologia, IDIBELL, L’Hospitalet de Llobregat. Barcelona, Spain
  • Raúl Murillo Centro Javeriano de Oncología, Hospital Universitario San Ignacio. Bogota, Colombia/Early Detection, Prevention & Infection Branch, International Agency for Research on Cancer. Lyon, France

DOI:

https://doi.org/10.21149/13204

Palabras clave:

uterine cervical neoplasms, papillomavirus infections, mass screening, public policy, HIV, Latin America

Resumen

Objective. To describe current cervical cancer screening program guidelines in Latin America. Materials and methods. We searched official recommendations for the general population and women living with HIV (WLHIV) by reviewing official sources from 19 countries; these data were supplemented with a consultation carried out by the WHO with the Ministries of Health. Results. Screening policies vary significantly in regard to target populations, primary tests, and screening intervals. Sixteen countries have recently updated their recommendations; however, cytology remains the primary screening test for most countries. Eleven countries have introduced HPV tests, and eight countries have implemented screen-and-treat algorithms; only three countries have developed evidence-based guidelines. All countries but Costa Rica have specific recommendations for WLHIV. Conclusions. Although most countries have updated their screening policies, only a few are properly alig­ned with the WHO elimination strategy. Recommendations for WLHIV require better integration with cervical cancer screening programs.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660

World Health Organization. Draft: Global Strategy towards the elimination of cervical cancer as a public health program. Geneva: WHO, 2020 [cited 2020 Jun 8]. Available from: https://www.who.int/publications/m/item/draft-global-strategy-towards-eliminating-cervical-cancer-as-a-public-health-problem

Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):575-90. https://doi.org/10.1016/S0140-6736(20)30068-4

International Agency for Research on Cancer. Global Cancer Observatory. Lyon: International Agency for Research on Cancer, 2020 [cited 2021 Jan 29]. Available from: https://gco.iarc.fr/

Almonte M, Murillo R, Sánchez GI, González P, Ferrera A, Picconi MA, et al. Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol. BMJ Open. 2020;10(5):e035796. https://doi.org/10.1136/bmjopen-2019-035796

Murillo R, Herrero R, Sierra MS, Forman D. Cervical cancer in Central and South America: Burden of disease and status of disease control. Cancer Epidemiol. 2016;44(1):S121-30. https://doi.org/10.1016/j.canep.2016.07.015

World Health Organization, Pan American Health Organization. Cancer country profiles. OMS, PAHO, 2020 [cited 2022 Jan 12]. Available from: https://www3.paho.org/hq/index.php?option=com_docman&view=list&slug=4-cancer-country-profiles-2020&Itemid=270&lang=es

World Health Organization. Comprehensive Cervical Cancer Control. A guide to essential practice. Geneva: WHO, 2014 [cited 2020 Sep 3]. Available from: https://www.who.int/reproductivehealth/publications/cancers/cervical-cancer-guide/en/

de Sanjose S, Holme F. What is needed now for successful scale-up of screening?Papillomavirus Res. 2019;7:173-5. https://doi.org/10.1016/j.pvr.2019.04.011

Pan American Health Organization. Plan of action for cervical cancer prevention and control 2018-2030. Washington DC: PAHO, 2018 [cited 2020 Jun 8]. Available from: https://www.paho.org/hq/index.php?option=com_docman&view=download&category_slug=mandates-strategies-3448&alias=47584-plan-cervical-cancer-2018-2030&Itemid=270&lang=en

Lynge E, Törnberg S, von Karsa L, Segnan N, van Delden JJM. Determinants of successful implementation of population-based cancer screening programmes. Eur J Cancer. 2012;48(5):743-8. https://doi.org/10.1016/j.ejca.2011.06.051

Murillo R. Social inequalities in cancer in Latin America. In: Vaccarella S, Lortet-Tieulent J, Saracci R, Conway DI, Straif K, Wild CP, editors. Reducing social inequalities in cancer: Evidence and priorities for research. Lyon: IARC Scientific Publication, 2019:223-6 [cited 2020 Jun 8]. Available from: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Scientific-Publications/Reducing-Social-Inequalities-In-Cancer-Evidence-And-Priorities-For-Research-2019

Instituto Nacional de Câncer, Ministério da Saúde. Diretrizes Brasileiras para o Rastreamento do Câncer do Colo do Útero. Rio de Janeiro: Inca, 2016 [cited 2020 Jun 8]. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//diretrizesparaorastreamentodocancerdocolodoutero_2016_corrigido.pdf

Ministerio de Salud. Guías Clínicas AUGE, Cáncer Cérvico Uterino. Santiago: Minsal, 2015 [cited 2020 Jun 8]. Available from: https://www.minsal.cl/wp-content/uploads/2015/09/GPC-CaCU.pdf

Ministerio de Salud y Protección Social. Guía de Práctica Clínica para la detección y manejo de lesiones precancerosas de cuello uterino. Colombia: Ministerio de Salud y Protección Social, 2014 [cited 2022 Jan 12]. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/CA/gpc-lesiones-precancerosas-cuello-uterino-padres.pdf

Secretaría de Salud. Programa de Acción Específico 2007-2012. Cáncer cervicouterino. Mexico City: Secretaría de Salud, 2008 [cited 2020 Jun 8]. Available from: http://www.cnegsr.salud.gob.mx/contenidos/descargas/CaCu/pae_cacu.pdf

Secretaría de Salud. Programa de acción específico, prevención y control del cáncer de la mujer 2013-2018. Mexico City: Secretaría de Salud, 2014 [cited 2020 Jun 8]. Available from: https://www.gob.mx/cms/uploads/attachment/file/10046/PrevencionyControldelCancerdelaMujer_2013_2018.pdf

Ministerio de Salud, Coordinación Nacional de Salud Sexual y Reproductiva. Normas de prevención, detección y seguimiento de las lesiones preinvasoras del cuello uterino y guías de manejo. Panamá: Ministerio de Salud, 2017 [cited 2020 Jun 8]. Available from: http://www.minsa.gob.pa/sites/default/files/programas/normas_de_prevencion_cacu.pdf

Arrossi S, Thouyaret L, Paul L. Prevención del cáncer cervicouterino. Recomendaciones para el tamizaje, seguimiento y tratamiento de mujeres en el marco de programas de tamizaje basados en el test de VPH: actualización. Buenos Aires: Instituto Nacional del Cáncer Argentina, 2015 [cited 2020 Jun 8]. Available from: https://bancos.salud.gob.ar/sites/default/files/2018-10/0000000017cnt-manual_recomendaciones_tamizaje_2015_baja.pdf

Secretaría de Salud. Protocolo para el tamizaje y tratamiento de lesiones premalignas para la prevención del cáncer cervicouterino. Honduras: Secretaría de Salud, 2015 [cited 2022 Jan 12]. Available from: https://ex-tranet.who.int/ncdccs/Data/HND_D1_Protocolo%20C%C3%A1ncer%20C%C3%A9rvicouterino%20(30%20NOV).pdf

Ministerio de Salud Pública y Asistencia Social. Guía de atención integral para la prevención, detección y tratamiento de lesiones precursoras del cáncer cérvico uterino. Guatemala: Ministerio de Salud Pública y Asistencia Social, 2020 [cited 2021 Feb 17]. Available from: https://osarguatemala.org/guia-de-atencion-integral-para-la-prevencion-deteccion-y-tratamiento-de-lesiones-precursoras-del-cancer-cervico-uterino/

Fernández-Deaza G, Caicedo-Martínez M, Serrano B, Roura E, Castillo JS, Silvia de S, et al. Appendix A and B. Figshare 2022. Available from: https://doi.org/10.6084/m9.figshare.20235681.v1

World Health Organization, International Agency for Research on Cancer, Working Group on the Evaluation of Cancer Preventive Agents. Cervix cancer screening. IARC Handbooks of Cancer Prevention. Lyon: IARC Press, 2005 [cited 2020 Jun 8]. Available from: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Handbooks-Of-Cancer-Prevention/Cervix-Cancer-Screening-2005

Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 2017;8(8):CD008587. https://doi.org/10.1002/14651858.CD008587.pub2

Chrysostomou A, Stylianou D, Constantinidou A, Kostrikis L. Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing. Viruses. 2018;10(12):729. https://doi.org/10.3390/v10120729

US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(7):674-86. https://doi.org/10.1001/jama.2018.10897

Canadian Task Force on Preventive Health Care. Recommendations on screening for cervical cancer. CMAJ. 2013;185(1):35-45. https://doi.org/10.1503/cmaj.121505

Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018;363:k4823. https://doi.org/10.1136/bmj.k4823

Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmerón J, Uribe P, Velasco-Mondragón E, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet. 2011;378(9806):1868-73. https://doi.org/10.1016/S0140-6736(11)61522-5

Arrossi S, Thouyaret L, Herrero R, Campanera A, Magdaleno A, Cuberli M, et al. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial. Lancet Glob Health. 2015;3(2):e85-94. https://doi.org/10.1016/S2214-109X(14)70354-7

Holme F, Jerónimo J, Maldonado F, Camel C, Sandoval M, Martínez- Granera B, et al. Introduction of HPV testing for cervical cancer screening in Central America: The Scale-Up project. Prev Med. 2020;135:106076. https://doi.org/10.1016/j.ypmed.2020.106076

Frenk J, Gómez-Dantés O. Health Systems in Latin America: The Search for Universal Health Coverage. Arch Med Res. 2018;49(2):79-83. https://doi.org/10.1016/j.arcmed.2018.06.002

Joint United Nations Programme on HIV/AIDS. Seazing the Moment; tackling entrenched inequalities to end epidemics. Geneva: UNAIDS, 2020 [cited 2020 Oct 5]. Available from: https://www.unaids.org/sites/default/files/media_asset/2020_global-aids-report_en.pdf

Joint United Nations Programme on HIV/AIDS. HIV estimates with uncertainty bounds from 1990-present. Geneva: UNAIDS, 2021 [cited 2022 Jan 12]. Available from: https://www.unaids.org/en/resources/docu-ments/2021/HIV_estimates_with_uncertainty_bounds_1990-present

Mohammed D, Shukla P, Babayants Y, Sison R, Slim J. Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016. Int J Womens Health. 2018;10:83-7. https://doi.org/10.2147/IJWH.S153003

Abraham AG, D’Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, et al. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. Acquir Immune Defic Syndr. 2013;62(4):405-13. https://doi.org/10.1097/QAI.0b013e31828177d7

World Health Organization. WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. Geneva: WHO, 2013 [cited 2020 Oct 5]. Available from: https://apps.who.int/iris/bitstream/handle/10665/94830/9789241548694_eng.pdf

Descargas

Publicado

2022-07-08

Cómo citar

1.
Fernández-Deaza G, Caicedo-Martínez M, Serrano B, Roura E, Castillo JS, de Sanjosé S, Bruni L, Murillo R. Cervical cancer screening programs in Latin America: current recommendations for facing elimination challenges. Salud Publica Mex [Internet]. 8 de julio de 2022 [citado 4 de junio de 2024];64(4, jul-ago):415-23. Disponible en: https://saludpublica.mx/index.php/spm/article/view/13204

Número

Sección

Artículo original

Artículos más leídos del mismo autor/a